Company Sernova Toronto S.E.

Stocks

SVA

CA81732W1041

Medical Equipment, Supplies & Distribution

Market Closed - Toronto S.E. 22:18:34 18/09/2026 +03			5-day change	1st Jan Change
0.1050 ^CAD	0.00%		-25.00%	-19.23%

09-11	Sernova Biotherapeutics Inc Reports Earnings Results for the Third Quarter and Nine Months Ended July 31, 2026	CI
09-08	Seraxis Holdings, Inc. entered into a definitive agreement to acquire Sernova Biotherapeutics Inc in a merger of equals, reverse merger transaction.	CI

Business description: Sernova

Sernova Biotherapeutics Inc. is a Canada-based clinical-stage company, which is focused on developing regenerative medicine therapeutics combining its Cell Pouch with human donor cells or stem cell-derived cell therapies to create bio-hybrid organs to treat chronic diseases. A bio-hybrid organ is comprised of non-biomaterials, such as the Cell Pouch, integrated with living tissues to restore or enhance the function of a compromised organ. This approach aims to deliver a potentially revolutionary treatment for patients with chronic diseases, initially focusing on type 1 diabetes (T1D) and thyroid disorders. Cell Pouch is a bio-hybrid organ which is surgically implanted beneath the skin of the abdomen.

Sales by Activity: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all business segments

Geographical breakdown of sales: Sernova

Fiscal Period: October	2021 (CAD)	2022 (CAD)	2023 (CAD)	2024 (CAD)	2025 (CAD)

See all geographic segments

Executive Committee: Sernova

Manager	Title	Age	Since
Jonathan Rigby CEO	Chief Executive Officer	58	12/08/2024
James Parsons DFI	Director of Finance/CFO	60	11/10/2024
David Burke IRC	Investor Relations Contact	-	11/10/2024
Marie Kaldchibachi PRN	Corporate Officer/Principal	-	-
Pericles Calias PRN	Corporate Officer/Principal	-	10/03/2025

See SERNOVA governance

Composition of the Board of Directors: Sernova

Director	Title	Age	Since
James Parsons BRD	Director/Board Member	60	19/04/2012
Steven Sangha BRD	Director/Board Member	-	24/04/2023
David Paterson BRD	Director/Board Member	-	01/09/2024
Bernd Mühlenweg BRD	Director/Board Member	54	01/04/2024
Tanya Lewis BRD	Director/Board Member	55	-
John Brooks CHM	Chairman	75	23/09/2025

Composition of the Board of Directors

Shareholders: Sernova

Name	Stocks	%	Valuation
Steven Sangha 10.51 %	39,703,667	10.51 %	3 M $
James Parsons 0.1627 %	614,605	0.1627 %	52 856 $
Jonathan Rigby 0.0609 %	229,877	0.0609 %	19 769 $
CATAM Asset Management AG 0.0397 %	150,000	0.0397 %	12 900 $
Archer Investment Corp. 0.003082 %	11,640	0.003082 %	1 001 $

List of SERNOVA shareholders

Company details: Sernova

Sernova Biotherapeutics, Inc.

700 Collip Circle

N6G 4X8, London

+917-751-5713

http://www.sernova.com

Medical Devices & Implants

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Change	5-day change	1-year change	3-year change	Capi.($)
STRYKER CORPORATION	-1.79%	+1.89%	-27.00%	-6.03%	107B
SMITH & NEPHEW PLC	-0.77%	+0.20%	-25.05%	-3.48%	11.63B
GLAUKOS CORPORATION	+1.48%	-3.86%	+99.52%	+118.06%	9.52B
IMEIK TECHNOLOGY DEVELOPMENT CO.,LTD.	+0.75%	+0.70%	-52.89%	-71.28%	3.99B
DOUBLE MEDICAL TECHNOLOGY INC.	+0.39%	-2.49%	-28.94%	+22.18%	2.33B
INSPIRE MEDICAL SYSTEMS, INC.	+5.55%	+12.71%	-4.02%	-63.60%	2.1B
INSIGHT LIFETECH CO., LTD.	+4.97%	+6.37%	-	-	1.84B
SHANGHAI MICROPORT ENDOVASCULAR MEDTECH CO., LTD.	+0.72%	-0.19%	-21.65%	-29.80%	1.52B
Average	+1.41%	+1.65%	-8.58%	-4.85%	17.55B
Weighted average by Cap.	-1.15%	+2.80%	-18.52%	+0.17%